Sydney Lupkin
Stories
-
Is taking acetaminophen during pregnancy really associated with autism in children?
President Trump's announcement this week linking Tylenol with autism could play a role in ongoing legal cases against the company that makes it.
-
They want COVID shots to protect their health or family. They can't get them
Though the FDA narrowed criteria for the shots, many people still want them, to avoid illness and protect vulnerable family members. Some are turned down at the pharmacy or have to jump through hoops.
-
COVID vaccine supply is ample, but so is confusion about access
As coverage of this year's crop of COVID boosters hangs in the balance under Robert F. Kennedy Jr.'s leadership, what is the vaccine supply situation this year?
-
Trump signs memo directing FDA to crack down on pharmaceutical ads
President Trump signed a memo on Tuesday directing the FDA to crack down on direct-to-consumer drug advertisements. But there are limits to what any administration can do.
-
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.
-
Why a new opioid alternative is out of reach for some pain patients
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
-
A new painkiller is providing an alternative to opioids, but many people can't get it
The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.
-
4 things to know about the vaccine ingredient thimerosal
Advisers to the Centers for Disease Control and Prevention recommended against flu shots containing the ingredient thimerosal. Why is the additive, safely used since the 1930s, being questioned again?
-
A new chapter for online sales of obesity drug alternatives tests legal limits
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, others are continuing and pushing regulatory boundaries.
-
Online sales of obesity drug alternatives carry on despite FDA deadlines
Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.
